GlassScriptPhysician profile
Haley Pilet
NPI 1609458512
$869.29
in general payments reported to CMS, 2019-2025
11 companies · $285 in 2025
The $285 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $204 · 2023: $341 · 2024: $39.48 · 2025: $285.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $665.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $665.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $343.32 | 2022-2025 | Lithovue, Accolade Sr, Rezum Generator |
| Endo Pharmaceuticals INC. | $105.39 | 2023 | Xiaflex |
| Progenics Pharmaceuticals, INC. | $91.51 | 2022-2025 | |
| Medtronic, INC. | $71.03 | 2024-2025 | Interstim |
| Astellas Pharma US INC | $65.00 | 2022 | |
| 180 Medical, INC. | $46.19 | 2022 | |
| Axogen | $42.67 | 2025 | |
| Sumitomo Pharma America, INC. | $33.61 | 2023 | Gemtesa |
| Innovation Technologies INC | $29.37 | 2023 | Irrisept |
| Photocure INC | $22.67 | 2025 | Cysview |
| Ferring Pharmaceuticals INC. | $18.53 | 2025 | Adstiladrin |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Haley Pilet listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.